Literature DB >> 29163968

Brushing the distal biliary stricture in the surrounding of the papilla increased the risk of post-endoscopic retrograde cholangiopancreatography pancreatitis: A retrospective study using propensity score analysis.

Kunihiro Kato1, Satoshi Sugimori1, Yuki Kakiya1, Hirotsugu Maruyama1, Shusei Fukunaga1, Yasuaki Nagami1, Masatsugu Shiba1, Tetsuya Tanigawa1, Toshio Watanabe1, Yasuhiro Fujiwara1.   

Abstract

BACKGROUND AND AIMS: Brushing cytology is useful for diagnosing biliary strictures. With regard to biliary stricture brushing at the distal common bile duct in the surrounding of the papilla, the risk of post-endoscopic retrograde cholangiopancreatography pancreatitis is unknown. Our study aimed to evaluate the risk of post-endoscopic retrograde cholangiopancreatography pancreatitis by using this procedure.
METHODS: A total of 150 endoscopic retrograde cholangiopancreatography-naïve patients undergoing endoscopic retrograde cholangiopancreatography including biliary stricture brushing were retrospectively analyzed. Patients were divided into two groups: the surrounding of the papilla group (n = 25) and the other group (n = 125). The primary outcome was the post-endoscopic retrograde cholangiopancreatography pancreatitis incidence. We analyzed the risk of post-endoscopic retrograde cholangiopancreatography pancreatitis by using inverse probability of treatment weighting based on propensity scores to adjust for selection bias.
RESULTS: The overall incidence of post-endoscopic retrograde cholangiopancreatography pancreatitis was 11.3%, and post-endoscopic retrograde cholangiopancreatography pancreatitis of the surrounding of the papilla group occurred significantly more frequently than in the other group (32.0% vs 7.2%, p < 0.01). Multivariate analysis showed that this procedure was a risk factor for post-endoscopic retrograde cholangiopancreatography pancreatitis (odds ratio, 10.6; 95% confidence interval, 2.82-40.2; p < 0.01). In the propensity-weighted model, this procedure was an independent risk factor for post-endoscopic retrograde cholangiopancreatography pancreatitis (odds ratio, 8.42; 95% confidence interval, 2.12-32.4; p < 0.01) by multivariate analysis.
CONCLUSIONS: Biliary stricture brushing at the distal common bile duct in the surrounding of the papilla may increase the risk of post-endoscopic retrograde cholangiopancreatography pancreatitis compared with brushing other portions.

Entities:  

Keywords:  Post-endoscopic retrograde cholangiopancreatography pancreatitis; biliary brushing cytology; inverse probability of treatment weighting; propensity score; risk factor

Year:  2017        PMID: 29163968      PMCID: PMC5676547          DOI: 10.1177/2050640617694279

Source DB:  PubMed          Journal:  United European Gastroenterol J        ISSN: 2050-6406            Impact factor:   4.623


  29 in total

1.  Complications of diagnostic and therapeutic ERCP: a prospective multicenter study.

Authors:  E Masci; G Toti; A Mariani; S Curioni; A Lomazzi; M Dinelli; G Minoli; C Crosta; U Comin; A Fertitta; A Prada; G R Passoni; P A Testoni
Journal:  Am J Gastroenterol       Date:  2001-02       Impact factor: 10.864

2.  Endoscopic transpapillary bile duct biopsy without sphincterotomy for diagnosing biliary strictures: a prospective comparative study with bile and brush cytology.

Authors:  M Sugiyama; Y Atomi; N Wada; A Kuroda; T Muto
Journal:  Am J Gastroenterol       Date:  1996-03       Impact factor: 10.864

3.  A lexicon for endoscopic adverse events: report of an ASGE workshop.

Authors:  Peter B Cotton; Glenn M Eisen; Lars Aabakken; Todd H Baron; Matt M Hutter; Brian C Jacobson; Klaus Mergener; Albert Nemcek; Bret T Petersen; John L Petrini; Irving M Pike; Linda Rabeneck; Joseph Romagnuolo; John J Vargo
Journal:  Gastrointest Endosc       Date:  2010-03       Impact factor: 9.427

4.  Triple-tissue sampling at ERCP in malignant biliary obstruction.

Authors:  J Jailwala; E L Fogel; S Sherman; K Gottlieb; J Flueckiger; L G Bucksot; G A Lehman
Journal:  Gastrointest Endosc       Date:  2000-04       Impact factor: 9.427

5.  Bedside scoring system to predict the risk of developing pancreatitis following ERCP.

Authors:  S Friedland; R M Soetikno; J Vandervoort; H Montes; T Tham; D L Carr-Locke
Journal:  Endoscopy       Date:  2002-06       Impact factor: 10.093

6.  Risk factors for post-ERCP pancreatitis: a prospective multicenter study.

Authors:  Chi-Liang Cheng; Stuart Sherman; James L Watkins; Jeffrey Barnett; Martin Freeman; Joseph Geenen; Michael Ryan; Harrison Parker; James T Frakes; Evan L Fogel; William B Silverman; Kulwinder S Dua; Giuseppe Aliperti; Paul Yakshe; Michael Uzer; Whitney Jones; John Goff; Laura Lazzell-Pannell; Abdullah Rashdan; M'hamed Temkit; Glen A Lehman
Journal:  Am J Gastroenterol       Date:  2006-01       Impact factor: 10.864

7.  The acute and long-term effect of balloon sphincteroplasty on papillary structure in pigs.

Authors:  P Mac Mathuna; D Siegenberg; D Gibbons; D Gorin; M O'Brien; N A Afdhal; R Chuttani
Journal:  Gastrointest Endosc       Date:  1996-12       Impact factor: 9.427

8.  Post-ERCP pancreatitis and hyperamylasemia: patient-related and operative risk factors.

Authors:  E Christoforidis; I Goulimaris; I Kanellos; K Tsalis; C Demetriades; D Betsis
Journal:  Endoscopy       Date:  2002-04       Impact factor: 10.093

9.  Endoscopic papillary large balloon dilation for treatment of large bile duct stones does not increase the risk of post-procedure pancreatitis.

Authors:  Jun Suk Park; Tae Nyeun Kim; Kook Hyun Kim
Journal:  Dig Dis Sci       Date:  2014-07-05       Impact factor: 3.199

10.  Efficacy and safety of low-pressured and short-time dilation in endoscopic papillary balloon dilation for bile duct stone removal.

Authors:  Takeshi Tsujino; Takao Kawabe; Hiroyuki Isayama; Takashi Sasaki; Hirofumi Kogure; Osamu Togawa; Toshihiko Arizumi; Yukiko Ito; Saburo Matsubara; Natsuyo Yamamoto; Yousuke Nakai; Naoki Sasahira; Kenji Hirano; Nobuo Toda; Yutaka Komatsu; Minoru Tada; Haruhiko Yoshida; Masao Omata
Journal:  J Gastroenterol Hepatol       Date:  2007-12-13       Impact factor: 4.029

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.